Chronic kidney disease (CKD) is associated with the development of mineral bone disorder
(MBD), osteoporosis, and fragility fractures. Among CKD patients, adynamic bone disease or …

Patients with CKD have a 4–fivefold higher rate of fractures. The incidence of fractures
increases with deterioration of kidney function. The process of skeletal changes in CKD …

Adynamic bone disease (ABD) is a well-recognized clinical entity in the complex chronic
kidney disease (CKD)–mineral and bone disorder. Although the combination of low intact …

Patients with chronic kidney disease (CKD) are at increased risk of osteoporosis and
vascular calcification. Bone demineralization and vascular mineralization go often hand in …

Patients with chronic kidney disease (CKD) have an increased fracture risk because of
impaired bone quality and quantity. Low bone mineral density predicts fracture risk in all …

BACKGROUND: Vascular calcification is common and constitutes a prognostic marker of
mortality in the hemodialysis population. Derangements of mineral metabolism may …

Chronic kidney disease (CKD)–mineral and bone disorder (CKD-MBD) is a term that
encompasses a constellation of abnormalities seen in progressive kidney disease that …

Most women with dialysis-dependent chronic kidney disease (CKD) stage 5 (CKD stage 5D)
are in the postmenopausal age group. Early menopause is reported for all CKD stages …

Results Baseline and first-year serum osteoprotegerin levels were significantly higher in the
progressive than nonprogressive group (17.39±9.67 versus 12.90±6.59 pmol/L, P= 0.02; …

Abstract Purpose of Review Chronic kidney disease (CKD) is associated with bone loss and
fractures. The purpose of this review is to provide clinicians with an overview of the …